Introduction

Unravelling Alzheimer’s: Innovations in Pathogenesis, Diagnosis, and Therapeutics provides a comprehensive and multidisciplinary exploration of Alzheimer’s Disease (AD), one of the most pressing neurodegenerative disorders of our time.

The book examines the historical evolution, epidemiology and global impact of AD, followed by an in-depth discussion on molecular and cellular mechanisms, including amyloid-beta aggregation, tau pathology, neuroinflammation, oxidative stress, and genetic factors. It highlights advances in biomarker discovery and early detection strategies, alongside cutting-edge diagnostic technologies such as neuroimaging and AI-driven tools. Case studies and patent insights further bridge research innovation with real-world clinical application.

Key Features

• - Comprehensive coverage of Alzheimer’s disease pathogenesis and molecular mechanisms.
• - Detailed analysis of biomarkers for early detection and therapeutic targeting.
• - Exploration of advanced diagnostic technologies and pharmacological advancements, including innovative drug delivery systems, neuroimaging technologies and AI-based tools.
• - In-depth discussion on novel therapies such as immunotherapy, gene therapy, RNA-based treatments, and natural compounds.
• - Case studies and recent developments linking research to clinical practice.
• - Integrated perspectives combining neuroscience, pharmacology, biotechnology, and clinical medicine.

Target Readership:

Clinicians, pharmaceutical scientists, healthcare professionals, R&D specialists, and industry practitioners working in neurodegenerative disease research and drug development.